incat score | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Keyword	CPC	PCC	Volume	Score	Length of keyword
incat score	1.44	0.8	775	80	11
incat	1.46	0.3	7416	34	5
score	0.57	0.9	3728	85	5

Keyword	CPC	PCC	Volume	Score
incat score	0.96	1	2987	15
incat score pdf	1.8	0.9	8985	39
incat score cidp	0.94	0.1	3031	41
incat score form	1.68	0.3	6418	18
incat score calculator	1.62	0.8	7214	59
incat score deutsch	0.72	0.3	8532	71
incat sensory sum score pdf	0.16	0.5	1875	49
incat disability scale score	1.96	0.3	7181	24
incat sensory sum score	1.32	0.5	65	75
incat disability score	0.3	0.3	7484	26
adjusted incat score	0.89	0.6	5446	44
incat disability score pdf	0.84	0.3	5328	47

Search Results related to incat score on Search Engine

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
polyneuroexchange.com

https://www.polyneuroexchange.com/cidp/assessment-tools

WEBThe INCAT comprises two parts, the arm score and the leg score 11; Based on a patient’s level of impairment in their arms and legs, each part is scored between 0 and 5 points, resulting in an INCAT total score between 0 and 10 11

DA: 28 PA: 83 MOZ Rank: 44

INCAT disability score: a critical analysis of its measurement
nih.gov

https://pubmed.ncbi.nlm.nih.gov/24723454/

WEBPMID: 24723454. DOI: 10.1002/mus.24207. Abstract. Background: The INCAT (Inflammatory Neuropathy Cause and Treatment) disability score is a measure of activity limitation. It is used frequently as a primary endpoint in …

DA: 88 PA: 27 MOZ Rank: 80

Getting closer to patients: the INCAT Overall Disability Sum Score
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077640/

WEBMar 20, 2006 · The INCAT ODSS combines arm and leg disability in a total score ranging from 0 (no signs of disability) to 12 (most severe disability score). 4 It provides a good functional description of the arms and legs in a checklist …

DA: 67 PA: 31 MOZ Rank: 68

Chronic Inflammatory Demyelinating Polyneuropathy
practicalneurology.com

https://practicalneurology.com/articles/2021-july-aug/chronic-inflammatory-demyelinating-polyneuropathy

WEBIn a 3-center retrospective study of 11 people with probable or definite CIDP who did not respond to conventional immune therapies, 9 of 11 had improved Inflammatory Neuropathy Cause and Treatment (INCAT) disability scores …

DA: 24 PA: 5 MOZ Rank: 52

Optimizing the Use of Outcome Measures in Chronic …
touchneurology.com

https://touchneurology.com/neuromuscular-diseases/journal-articles/optimizing-the-use-of-outcome-measures-in-chronic-inflammatory-demyelinating-polyneuropathy/

WEBApr 11, 2017 · A number of outcome measures have been validated for this purpose. Disability outcomes include the adjusted inflammatory neuropathy cause and treatment (INCAT) disability score, INCAT overall disability sum score (ODSS), and overall neuropathy limitations scale (ONLS).

DA: 46 PA: 80 MOZ Rank: 61

Comprehensive approaches for diagnosis, monitoring and …
biomedcentral.com

https://neurolrespract.biomedcentral.com/articles/10.1186/s42466-020-00088-8

WEBDec 8, 2020 · The INCAT-Overall Disability Sum Score (ODSS), first described in 2002, is well-established and validated for patients with CIDP and has developed into a standard score for CIDP . Yet, this score poorly detects discrete changes of disability or sensory symptoms.

DA: 35 PA: 60 MOZ Rank: 35

Treatment Approaches for Atypical CIDP - PMC - National Center …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005557/

WEBMar 15, 2021 · Factors such as INCAT disability scores and time to walk 10 m improved with rituximab treatment (19, 20). However, the INCAT sensory sum score which reflects the sensory deficits, did not show improvement creating doubts that this scale is the ideal outcome measure to use in the DADS phenotype ( 21 ).

DA: 58 PA: 78 MOZ Rank: 41

INCAT disability score: a critical analysis of its measurement
europepmc.org

https://europepmc.org/article/MED/24723454

WEBMay 17, 2014 · The INCAT (Inflammatory Neuropathy Cause and Treatment) disability score is a measure of activity limitation. It is used frequently as a primary endpoint in inflammatory polyneuropathy clinical trials. A comprehensive critical analysis of its measurement properties has not been performed.

DA: 88 PA: 18 MOZ Rank: 34

Assessing the benefit of treatment in chronic inflammatory
futuremedicine.com

https://www.futuremedicine.com/doi/10.2217/nmt-2018-0027

WEBSep 18, 2018 · Scales such as the INCAT and ONLS offer rapid evaluation of change, with minimal examiner training and take a very short time to administer. A clinician familiar with the scale is usually able to score an individual patients in a few minutes.

DA: 75 PA: 24 MOZ Rank: 41

Getting closer to patients: the INCAT Overall Disability Sum Score
bmj.com

https://jnnp.bmj.com/content/77/8/970

WEBGetting closer to patients: the INCAT Overall Disability Sum Score relates better to patients’ own clinical judgement in immune-mediated polyneuropathies | Journal of Neurology, Neurosurgery & Psychiatry. Home. Archive. Volume 77, Issue 8. Email alerts. PDF.

DA: 40 PA: 57 MOZ Rank: 65